Literature DB >> 25542625

Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.

Anju E Joham1, Jacqueline A Boyle2, Sophia Zoungas1, Helena J Teede3.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common disorder with metabolic complications, yet the prevalence of hypertension is unclear. We aim to assess hypertension prevalence and the impact of obesity in women reporting PCOS compared to those not reporting PCOS.
METHODS: This is a cross-sectional analysis of data from a large longitudinal study, the Australian Longitudinal Study on Women's Health (ALSWH). Women from the general community were randomly selected from the national health insurance database. Standardized data collection occurred at 6 survey time points. Data from Survey 4 in 2006 (n = 8,612, age: 28-33 years) were examined for this study. The main outcome measures studied were self-reported PCOS and hypertension.
RESULTS: Reported PCOS prevalence was 5.8% (95% confidence interval (CI): 5.3%-6.4%). Women with PCOS had higher body mass index (BMI). Hypertension prevalence was 5.5% (95% CI: 3.3-7.7) in women reporting PCOS and 2.0% (95% CI: 1.6-2.3) in women not reporting PCOS (P < 0.001). Hypertension was associated with BMI (odds ratio: 1.07, 95% CI: 1.05-1.10, P < 0.001) with a trend towards an association with PCOS (P = 0.09). On subgroup analysis, hypertension was not associated with BMI in women reporting PCOS but was associated in those not reporting PCOS.
CONCLUSIONS: In this large community-based cohort, we note increased prevalence of hypertension and higher BMI in young women reporting PCOS. BMI association with hypertension appeared clear in women not reporting PCOS. Yet in women with PCOS, hypertension appeared to not be associated with BMI, akin to observations on diabetes risk in PCOS, suggesting that metabolic abnormalities in PCOS may be independent of BMI. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  PCOS.; blood pressure; hypertension; obesity

Mesh:

Year:  2014        PMID: 25542625     DOI: 10.1093/ajh/hpu251

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  28 in total

Review 1.  Hypertension in Premenopausal and Postmenopausal Women.

Authors:  Yasmin Brahmbhatt; Maitreyee Gupta; Seyed Hamrahian
Journal:  Curr Hypertens Rep       Date:  2019-08-26       Impact factor: 5.369

2.  Menstrual cycle characteristics and incident cancer: a prospective cohort study.

Authors:  Siwen Wang; Yi-Xin Wang; Helena Sandoval-Insausti; Leslie V Farland; Jan L Shifren; Dan Zhang; JoAnn E Manson; Brenda M Birmann; Walter C Willett; Edward L Giovannucci; Stacey A Missmer; Jorge E Chavarro
Journal:  Hum Reprod       Date:  2022-01-28       Impact factor: 6.918

3.  Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.

Authors:  Meri-Maija E Ollila; Kari Kaikkonen; Marjo-Riitta Järvelin; Heikki V Huikuri; Juha S Tapanainen; Stephen Franks; Terhi T Piltonen; Laure Morin-Papunen
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

4.  Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.

Authors:  Roberto Mioni; Anna Dalla Cà; Jenni Turra; Sara Azzolini; Nadia Xamin; Luigi Bleve; Pietro Maffei; Roberto Vettor; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-03       Impact factor: 3.633

5.  Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.

Authors:  Patricia A Hunt; Sheela Sathyanarayana; Paul A Fowler; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2016-03-22       Impact factor: 5.958

6.  Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.

Authors:  Panicha Chantrapanichkul; Suchada Indhavivadhana; Thanyarat Wongwananuruk; Kitirat Techatraisak; Chongdee Dangrat; Nutchaya Sa-Nga-Areekul
Journal:  Arch Gynecol Obstet       Date:  2020-01-11       Impact factor: 2.493

7.  Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta.

Authors:  Jay S Mishra; Gary D Hankins; Sathish Kumar
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-10-19       Impact factor: 1.636

8.  Shift Work Is Associated with Metabolic Syndrome in Young Female Korean Workers.

Authors:  Kyoung Hwa Yu; Yu Hyeon Yi; Yun Jin Kim; Byung Mann Cho; Sang Yeoup Lee; Jeong Gyu Lee; Dong Wook Jeong; So Yeon Ji
Journal:  Korean J Fam Med       Date:  2017-03-22

Review 9.  Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review.

Authors:  Marzieh Saei Ghare Naz; Fahimeh Ramezani Tehrani; Tahereh Behroozi-Lak; Farnaz Mohammadzadeh; Farhnaz Kholosi Badr; Giti Ozgoli
Journal:  Res Rep Urol       Date:  2020-05-07

10.  Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women.

Authors:  Sang Su Lee; Do Hoon Kim; Ga-Eun Nam; Hyo-Yun Nam; Young Eun Kim; Sung Ho Lee; Kyung Do Han; Yong Gyu Park
Journal:  Korean J Fam Med       Date:  2016-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.